We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Home » Merck Seeks Ridaforolimus Marketing Approval From EMA
Merck Seeks Ridaforolimus Marketing Approval From EMA
August 2, 2011
Merck has filed a marketing authorization application (MAA) for ridaforolimus with the European Medicines Agency (EMA). PBR
